Document is current
Any future updates will be listed below
-
Authors
Weyand, Anna Maria
Cordes, Natascha
Linka, Louise
Strehlau, Sascha
Tsalouchidou, Panagiota-Eleni
Carl, Barbara
Gjorgjevsky, Marko
Grote, Alexander
Nimsky, Christopher
Möller, Leona
Habermehl, Lena
Zahnert, Felix
Strzelczyk, Adam
Rosenow, Felix
Münchberger, Christina
Hakel, Lukas
Menzler, Katja
Immisch, Ilka
Krause, Kristina
Knake, Susanne
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Accepted: 8 October 2025
First Online: 20 November 2025
Declarations
:
: S. Knake received speaker’s honoraria from Bial, Destin Arzneimittel, Eisai, Jazz Pharma, Merck Serono and UCB. C. Nimsky is scientific consultant for Brainlab, BK medical, and Zeiss. F. Rosenow has received personal fees from Angelini Pharma, Desitin Arzneimittel, Eisai GmbH, Jazz Pharma, Roche Pharma, Stoke therapeutics and UCB Pharma and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Deutsche Forschungsgemeinschaft (DFG), the Federal Ministry of Education and Research (BMBF), the LOEWE Programme of the State of Hesse, and the European Union. A. Strzelczyk has received personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz Pharmaceuticals, Takeda, UCB Pharma, and UNEEG Medical. F. Rosenow and A. Strzelczyk are members of the editorial board of Clinical Epileptology . A.M. Weyand, N. Cordes, L. Linka, S. Strehlau, P.-E. Tsalouchidou, B. Carl, M. Gjorgjevsky, A. Grote, L. Möller, L. Habermehl, F. Zahnert, C. Münchberger, L. Hakel, K. Menzler, I. Immisch, and K. Krause declare that they have no competing interests.
: Ethics committee approval was obtained, and since it was a retrospective study, informed consent was waived. The study adhered closely to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
